Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders

Hybrid SCFA-hydroxyl-derivatized monosaccharides, methods of synthesis, and methods of treating disorders

US Patent 8916544 · Granted Dec 23, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Target reporter constructs and uses thereof2025
Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathwa2023
Target reporter constructs and uses thereof2022
Use of high flux SCFA-derivatized monosaccharides in recombinant glycoprotein pr2021
Use of high flux SCFA-derivatized monosaccharides in recombinant glycoprotein pr2021
Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathwa2021
Short-chain fatty acid hexosamine analogs and their use in tissue engineering ap2019
Short-chain fatty acid hexosamine analogs and their use in tissue engineering ap2019
Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods there2016
Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods there2016
Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods there2016
Fatty acid carbohydrate hybrid molecules as therapeutic agents and methods there2016